Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection

Bestatin, an inhibitor of leucine aminopeptidase (LAPase), significantly decreased HIV infection as reflected by a reduced number of positive immunofluorescent cells, p24 levels, reverse transcriptase activity and the number of proviral copies found in Bestatin-treated cells. Cellular and extracellu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulido-Cejudo, Gabriel, Conway, Brian, Proulx, Pierre, Brown, Robert, Izaguirre, Carlos A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science B.V. 1997
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172372/
https://www.ncbi.nlm.nih.gov/pubmed/9477117
http://dx.doi.org/10.1016/S0166-3542(97)00052-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172372/
https://www.ncbi.nlm.nih.gov/pubmed/9477117
http://dx.doi.org/10.1016/S0166-3542(97)00052-1

Ejemplares similares